Table I.
Patient | Histology | ER/PR/HER2 Status | TNM Staging | HLA-A2 Status |
---|---|---|---|---|
Breast #1 | IDC | ER−/PR−/HER2− | T1cNXMX | Positive |
Breast #2 | IDC | ER−/PR−/HER2+ | T2N1bMX | N/D |
Breast #3 | IDC/ILC | ER+/HER2+ | T2N1aMX | Negative |
Breast #4 | IDC | ER−/HER2− | T3N0MX | Positive |
Melanoma #1 | Nodular | N/A | T3N2M1c | Positive |
Melanoma #2 | N/D | N/A | T3N2M1b | Negative |
Abbreviations: IDC, invasive ductal carcinoma; ILC, invasive lobular carcinoma; ER, estrogen receptor; PR, progesterone receptor; HER2, HER2/neu; N/D, not determined.